Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been granted an extension to its existing UK approval, for 12- to 17-year-olds. This extension has been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).
Information for healthcare professionals and the public on Moderna s bivalent vaccine. Information on the original Spikevax COVID-19 vaccine can found on a separate page (link below)
Travere Therapeutics (TVTX) Provides Regulatory Updates on Development Programs streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.